Cargando…
Identification of lineariifolianoid A as a novel dual NFAT1 and MDM2 inhibitor for human cancer therapy
There is an increasing interest in development of novel anticancer agents that target oncogenes. We have recently discovered that nuclear factor of activated T cells 1 (NFAT1) is a novel regulator of the Mouse Double Minute 2 (MDM2) oncogene and the NFAT1-MDM2 pathway has been implicated in human ca...
Autores principales: | Qin, Jiang-Jiang, Sarkar, Sushanta, Voruganti, Sukesh, Agarwal, Rajesh, Wang, Wei, Zhang, Ruiwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Department of Journal of Biomedical Research
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946323/ https://www.ncbi.nlm.nih.gov/pubmed/27533941 http://dx.doi.org/10.7555/JBR.30.20160018 |
Ejemplares similares
-
Inulanolide A as a new dual inhibitor of NFAT1-MDM2 pathway for breast cancer therapy
por: Qin, Jiang-Jiang, et al.
Publicado: (2016) -
Inhibiting NFAT1 for breast cancer therapy: New insights into the mechanism of action of MDM2 inhibitor JapA
por: Qin, Jiang-Jiang, et al.
Publicado: (2015) -
Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation
por: Qin, Jiang-Jiang, et al.
Publicado: (2014) -
Two Birds with One Stone: NFAT1-MDM2 Dual Inhibitors for Cancer Therapy †
por: Wang, Wei, et al.
Publicado: (2020) -
Oral nano-delivery of anticancer ginsenoside 25-OCH(3)-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti-prostate cancer activity, and mechanisms of action
por: Voruganti, Sukesh, et al.
Publicado: (2015)